The Indian primary market continues its robust momentum as the market regulator, Securities and Exchange Board of India (SEBI), has accelerated its observation process. The regulator has granted the green light to seven companies to float their IPOs. These approvals span across sectors including real estate, chemicals, logistics, and healthcare, signalling a healthy appetite for varied asset classes. While seven firms received the go-ahead, one issue—Deon Energy—was either withdrawn or returned, highlighting the stringent vetting process maintained by the regulator.
Here is a detailed look at the seven companies that have received the SEBI nod:
Gaudium IVF IPO Approval
Gaudium IVF and Women Health has received the regulator’s nod for its public listing. This IPO is a mix of a fresh issue (1,13,92,500 shares) and an offer for sale (94,93,700 shares). Gaudium has built a reputable brand in the fertility and reproductive health space, a sector that is seeing increased corporatisation and institutional investment. The issue is being managed by Sarthi Capital Advisors.
Gaudium IVF filed its preliminary papers on 30 September 2025 and received the final observation letter on 15 January 2026. The fertility market in India remains highly fragmented, and Gaudium intends to use the fresh capital to expand its network of clinics across Tier-2 and Tier-3 cities and to invest in advanced embryology equipment.
Silverton Industries IPO Approval
Silverton Industries has successfully cleared the regulatory hurdle to launch its maiden public issue. The company, which operates in the industrial manufacturing space, is looking to capitalize on the “Make in India” sentiment. The IPO is structured as a combination of a Fresh Issue (~INR 300 crore) and an Offer for Sale (3,22,00,000), allowing the company to raise primary capital for growth while providing an exit or partial divestment opportunity for existing shareholders. The issue is being managed by Pantomath Capital Advisors, a firm known for bringing quality mid-cap industrial players to the floor.
Silverton Industries filed its Draft Red Herring Prospectus (DRHP) on 2 July 2025. After a thorough review process lasting approximately six months, SEBI issued its final observations on 12 January 2026.
Supreet Chemicals IPO Approval
The speciality chemicals sector continues to be a favourite among investors, and Supreet Chemicals is the latest entrant to receive the SEBI nod. Interestingly, the company has opted for a “Fresh Issue (INR 499 crore)” structure, indicating that 100% of the proceeds raised from the public will flow directly into the company’s books for expansion, research and development, or working capital requirements. This move is often viewed favourably by the market as it shows management’s commitment to retaining its skin in the game.
The company filed its DRHP with the regulator on 9 September 2025 and received the observation letter on 16 January 2026. IIFL Capital Services is acting as the sole Book Running Lead Manager for this issue.
CJ Darcl IPO Approval
CJ Darcl Logistics, one of India’s leading end-to-end transport and logistics players, has received approval for its IPO, which consists of both a Fresh Issue (2,64,70,000 shares) and an Offer for Sale (99,05,355 shares). The logistics sector has seen a massive transformation with the implementation of GST and the growth of e-commerce, making CJ Darcl a high-interest candidate for institutional investors. The company provides a wide range of services including full truckload (FTL) shipping, cold chain solutions, and project cargo.
The company submitted its DRHP on 30 September 2025 and secured SEBI’s approval on 14 January 2026. ICICI Securities is the coordinating lead manager for this significant issue.
Runwal Developers IPO Approval
One of the most anticipated approvals this week is for Runwal Developers, a powerhouse in the Mumbai real estate market. The IPO, which is a combination of a Fresh Issue (~INR 1,700 crore) and an Offer for Sale (~INR 300 crore), marks the entry of another major developer into the equity markets. Known for its luxury residential projects and sprawling retail malls, Runwal Developers is looking to strengthen its balance sheet and fund the construction of its ongoing and upcoming projects.
The real estate major filed its DRHP on 8 October 2025 and received the SEBI green light on 13 January 2026. ICICI Securities is managing the book-building process.
Lalbaba Engineering IPO Approval
Lalbaba Engineering has received approval for its IPO comprising a Fresh Issue (~INR 630 crore) and an Offer for Sale (INR 370 crore). The company, which specialises in engineering components and specialised manufacturing for the infrastructure and energy sectors, has been a steady performer in the industrial space. The issue is being managed by IIFL Capital Services.
The company’s DRHP was filed on 8 October 2025, and SEBI issued the observation letter on 13 January 2026. The engineering firm intends to use the capital from the fresh issue to fund its working capital requirements and for general corporate purposes.
Augmont Enterprises IPO Approval
Augmont Enterprises, a prominent name in the integrated gold ecosystem, has received the regulator’s nod to go public. The IPO includes both a Fresh Issue (INR 620 crore) and an Offer for Sale (~INR 180 crore). Augmont is a unique player that spans the entire value chain of precious metals, from refining and bullion trading to digital gold and jewelry retail. The company has gained significant traction through its digital platform, making gold investment accessible to a wider demographic.
The company filed its DRHP on 8 October 2025 and received approval on 12 January 2026. Nuvama Wealth Management is the coordinating lead manager for the issue.
Amidst these seven approvals, Deon Energy IPO was withdrawn/returned on 8 January 2026. The company had originally filed its DRHP on 7 October 2025 through Smart Horizon Capital Advisors. While the specific reasons for the withdrawal were not immediately disclosed.
For more details related to IPO GMP, SEBI IPO Approval, and Live Subscription stay tuned to IPO Central.